Last 12 months
Inside the activity.
10 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 5 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2016 Filed Dec 5, 2016 21:07 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
SaleCommon Stock | 26,726 | $20.48 | $547,367.19 |
DisclosureSEC source: 0001225208-16-042699 · doc4.xml · nonDerivative · entry 2 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,704 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $20.422 to $20.515, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 21:07 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
Exercise / conversionCommon Stock | 18,761 | $13.56 | $254,399.16 |
DisclosureSEC source: 0001225208-16-042699 · doc4.xml · nonDerivative · entry 1 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 20:50 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $13.56 | $0.00 |
DisclosureSEC source: 0001225208-16-041120 · doc4.xml · derivative · entry 3 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,761 Underlying: Common Stock · 17,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments commencing on May 1, 2009, the first anniversary of the date of grant Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 20:50 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
SaleCommon Stock | 24,752 | $21.89 | $541,826.23 |
DisclosureSEC source: 0001225208-16-041120 · doc4.xml · nonDerivative · entry 2 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,669 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $21.8321 to $22.0128, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 20:50 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
Exercise / conversionCommon Stock | 17,000 | $13.56 | $230,520.00 |
DisclosureSEC source: 0001225208-16-041120 · doc4.xml · nonDerivative · entry 1 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 20:54 UTC |
Mahoney Michael FDirector · President & CEO
|
Exercise / conversionDeferred Stock Units · Derivative | 341,670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-041123 · doc4.xml · derivative · entry 4 Mahoney Michael F · CIK 0001533022 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 341,670 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on November 1, 2012, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on November 1, 2012, the first anniversary of the date of grant. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 20:54 UTC |
Mahoney Michael FDirector · President & CEO
|
Tax withholdingCommon Stock | 160,756 | $21.71 | $3,490,012.76 |
DisclosureSEC source: 0001225208-16-041123 · doc4.xml · nonDerivative · entry 3 Mahoney Michael F · CIK 0001533022 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517,091 Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 20:54 UTC |
Mahoney Michael FDirector · President & CEO
|
Exercise / conversionCommon Stock | 341,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-041123 · doc4.xml · nonDerivative · entry 2 Mahoney Michael F · CIK 0001533022 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,677,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| October 29, 2016 Filed Nov 1, 2016 20:09 UTC |
Thepaut Eric Francis YvesSVP & Pres, Europe
|
Exercise / conversionDeferred Stock Units · Derivative | 1,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040922 · doc4.xml · derivative · entry 3 Thepaut Eric Francis Yves · CIK 0001631992 · SVP & Pres, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,393 Underlying: Common Stock · 1,696 shares Expires 2018-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 29, 2014, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 29, 2014, the first anniversary of the date of grant. Read SEC document |
| October 29, 2016 Filed Nov 1, 2016 20:09 UTC |
Thepaut Eric Francis YvesSVP & Pres, Europe
|
Tax withholdingCommon Stock | 374 | $22.09 | $8,261.66 |
DisclosureSEC source: 0001225208-16-040922 · doc4.xml · nonDerivative · entry 2 Thepaut Eric Francis Yves · CIK 0001631992 · SVP & Pres, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,417.99 Read SEC document |
| October 29, 2016 Filed Nov 1, 2016 20:09 UTC |
Thepaut Eric Francis YvesSVP & Pres, Europe
|
Exercise / conversionCommon Stock | 1,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040922 · doc4.xml · nonDerivative · entry 1 Thepaut Eric Francis Yves · CIK 0001631992 · SVP & Pres, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,791.99 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 20:40 UTC |
Thepaut Eric Francis YvesSVP & Pres, Europe
|
Exercise / conversionDeferred Stock Units · Derivative | 3,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040791 · doc4.xml · derivative · entry 3 Thepaut Eric Francis Yves · CIK 0001631992 · SVP & Pres, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,690 shares Expires 2016-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 25, 2012, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 25, 2012, the first anniversary of the date of grant. Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 20:40 UTC |
Thepaut Eric Francis YvesSVP & Pres, Europe
|
Tax withholdingCommon Stock | 812 | $22.44 | $18,221.28 |
DisclosureSEC source: 0001225208-16-040791 · doc4.xml · nonDerivative · entry 2 Thepaut Eric Francis Yves · CIK 0001631992 · SVP & Pres, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,095.99 Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 20:40 UTC |
Thepaut Eric Francis YvesSVP & Pres, Europe
|
Exercise / conversionCommon Stock | 3,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040791 · doc4.xml · nonDerivative · entry 1 Thepaut Eric Francis Yves · CIK 0001631992 · SVP & Pres, Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,907.99 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:04 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $13.56 | $0.00 |
DisclosureSEC source: 0001225208-16-040027 · doc4.xml · derivative · entry 3 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,761 Underlying: Common Stock · 17,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments commencing on May 1, 2009, the first anniversary of the date of grant. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:04 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
SaleCommon Stock | 24,000 | $23.54 | $564,969.60 |
DisclosureSEC source: 0001225208-16-040027 · doc4.xml · nonDerivative · entry 2 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,421 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.5000 to $23.6669, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:04 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
Exercise / conversionCommon Stock | 17,000 | $13.56 | $230,520.00 |
DisclosureSEC source: 0001225208-16-040027 · doc4.xml · nonDerivative · entry 1 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:09 UTC |
MACMILLAN STEPHEN PDirector
|
GrantStock Option (Right to Buy) · Derivative | 796 | $0.00 Strike: $23.50 | $0.00 |
DisclosureSEC source: 0001225208-16-040184 · doc4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 796 Underlying: Common Stock · 796 shares Expires 2026-10-03 F4 · shares: Reporting person received 25% of the cash compensation for the third quarter of 2016 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2017 annual meeting of stockholders. F4 · derivative.exercise_date: Reporting person received 25% of the cash compensation for the third quarter of 2016 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2017 annual meeting of stockholders. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:09 UTC |
MACMILLAN STEPHEN PDirector
|
GrantDeferred Stock Units · Derivative | 718 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040184 · doc4.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,446 Underlying: Common Stock · 718 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · shares: Reflects a value of $16,875 divided by the closing price of common stock on the date of grant. F3 · derivative.exercise_date: Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. F3 · derivative.expiration_date: Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:08 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $13.56 | $0.00 |
DisclosureSEC source: 0001225208-16-038809 · doc4.xml · derivative · entry 3 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,761 Underlying: Common Stock · 17,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments commencing on May 1, 2009, the first anniversary of the date of grant. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:08 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
SaleCommon Stock | 24,074 | $24.10 | $580,072.66 |
DisclosureSEC source: 0001225208-16-038809 · doc4.xml · nonDerivative · entry 2 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,421 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.0701 to $24.1116, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:08 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
Exercise / conversionCommon Stock | 17,000 | $13.56 | $230,520.00 |
DisclosureSEC source: 0001225208-16-038809 · doc4.xml · nonDerivative · entry 1 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| August 22, 2016 Filed Nov 3, 2016 20:54 UTC |
Mahoney Michael FDirector · President & CEO
|
GiftCommon Stock | 52,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-041123 · doc4.xml · nonDerivative · entry 1 Mahoney Michael F · CIK 0001533022 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,336,177 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.